collagenase clostridium histolyticum (CCH, Xiaflex, Qwo)
Jump to navigation
Jump to search
Indications
- Dupuytren's contracture
- Peyronie's disease (FDA-approved Ded 2013)
Dosage
- 0.58 mg into the contracted collagen cord
- injections every 30-day intervals
- joint manipulation one day after injection
More general terms
Additional terms
References
- ↑ Hurst LC et al, Injectable Collagenase Clostridium Histolyticum for Dupuytren's Contracture N Engl J Med 2009, 361:968-979 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/19726771 <Internet> http://content.nejm.org/cgi/content/short/361/10/968
- ↑ FDA News Release: Dec. 6, 2013 FDA approves first drug treatment for Peyronie's disease. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm377849.htm